#MRNA announced it is presenting at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) August Meeting today. The live presentation can be viewed online here.
This presentation will include new interim safety and immunogenicity data from the cohorts of older adults in the NIH-led Phase 1 study of mRNA-1273, Moderna’s vaccine candidate against COVID-19. The ACIP presentation slides will be available under “Events and Presentations” in the Investors section of the Moderna website.
Learn more at our AmpCard.